Related Experiment Videos
[Preliminary study on arsenic trioxide induced Tca8113 cell apoptosis]
Yue-ping Wang1, Han-guang Zhu, Zhi-yuan Zhang
1Department of Oral & Maxillofacial Surgery, Ninth People's Hospital, Shanghai Second Medical University, Shanghai 200001, China.
Shanghai Kou Qiang Yi Xue = Shanghai Journal of Stomatology
|February 26, 2004
Summary
Arsenic trioxide shows potential in treating oral squamous cell carcinoma by inducing apoptosis. This study investigated its effects on cancer cell growth and survival.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Oral squamous cell carcinoma (OSCC) is a prevalent cancer with limited treatment options.
- Apoptosis, or programmed cell death, is a key mechanism targeted in cancer therapy.
- Arsenic trioxide is a compound with known cytotoxic properties.
Purpose:
- To investigate the potential of arsenic trioxide (As2O3) in inducing apoptosis in oral squamous cell carcinoma.
- To evaluate the effects of arsenic trioxide on the proliferation and survival of OSCC cells in vitro.
Summary:
- In vitro studies using the Tca8113 human tongue squamous cell carcinoma cell line demonstrated that arsenic trioxide effectively induces apoptosis.
- Arsenic trioxide treatment inhibited the growth and survival of OSCC cells.
- Flow cytometry, fluoroscopy, and electron microscopy were employed to assess the cellular effects.
Impact:
- Arsenic trioxide represents a potential therapeutic agent for oral squamous cell carcinoma.
- Understanding the apoptotic mechanisms of arsenic trioxide can inform future cancer treatment strategies.
- This research contributes to the development of novel chemotherapeutic approaches for OSCC.